Zts stock price analysts note ZTS stock price

Analysts note ZTS stock price resilience against macro headwinds like interest rate uncertainty, underpinned by non-cyclical demand in veterinary pharma solutions. The products it creates with its customers range from its largest business line, robot-assisted surgical (RAS) drapes, to medical-surgical beds, needleless injection port cleaners, and revascularization devices. Simply put, UFP dominates an array of unique niches in the medical device industry. Most importantly for investors, the vast majority of the company's sales come from single-use, single-patient products that provide recurring, predictable sales. Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks. In the short run, traders forecast ZTS stock price targeting $178 resistance, supported by higher volume breakout patterns spotted in recent trading sessions.